Event dossier

Lung cancer patients on drug from China’s Akeso lived longer

Patients on ivonescimab lived longer by four months compared with those on immunotherapy.

1 report1 sourceMay 31, 2026, 2:06 PM
FilterThe Straits Times
Clustered coverageThe Straits Times
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

The Straits TimesMay 31, 2026, 2:06 PM

Lung cancer patients on drug from China’s Akeso lived longer

Patients on ivonescimab lived longer by four months compared with those on immunotherapy.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.